PTC Therapeutics is transitioning from a legacy rare disease business to a growth-focused model. Read why PTCT stock is a Buy ...
Shares of PTC Therapeutics (PTCT) added ~19% on Friday to reach the highest level since January after the rare disease ...
PTC Therapeutics (NASDAQ:PTCT) reported a record first quarter for product revenue and raised its 2026 revenue outlook, citing strong early demand for Sephience, its treatment for phenylketonuria, or ...
PTC (NASDAQ: PTC) today announced the U.S. Army has designated the Windchill® product lifecycle management (PLM) solution as ...
Q1 2026 earnings call recap: record revenue, raised 2026 guidance, Sephience launch momentum, Japan entry & pipeline ...
Detailed price information for Ptc Therapeutics (PTCT-Q) from The Globe and Mail including charting and trades.
StockStory.org on MSN
PTC (PTC) shares skyrocket, what you need to know
What Happened? Shares of product design software company PTC (NASDAQ:PTC) jumped 8.9% in the afternoon session after the ...
PTC Therapeutics draws market attention after a stronger quarterly update highlights rare disease focus and healthcare sector ...
Phase 2 data from PTC Therapeutics showed that the Novartis-partnered Huntington’s disease asset slowed progression by more ...
May 6 - PTC Inc on Wednesday raised its full-year revenue forecast, citing continued demand from manufacturers using its software to digitize their design and production processes. Shares of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results